SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-22-010614
Filing Date
2022-04-26
Accepted
2022-04-26 17:14:20
Documents
12
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A aveodef14a2022combined.htm DEF 14A 1118544
2 GRAPHIC aveo-pcx4x13x22mbxip001.jpg GRAPHIC 158383
3 GRAPHIC aveo-pcx4x13x22mbxip002.jpg GRAPHIC 126698
4 GRAPHIC aveologoa.jpg GRAPHIC 9024
5 GRAPHIC calculatora.jpg GRAPHIC 1867
6 GRAPHIC envelopesymbola.jpg GRAPHIC 8258
7 GRAPHIC governmentbuildingimagea.jpg GRAPHIC 8222
8 GRAPHIC imagea.jpg GRAPHIC 849
9 GRAPHIC laptopsymbola.jpg GRAPHIC 6559
10 GRAPHIC michaelbaileysignaturea.jpg GRAPHIC 2922
11 GRAPHIC piechartsymbola.jpg GRAPHIC 1817
12 GRAPHIC textmobilesymbola.jpg GRAPHIC 7528
  Complete submission text file 0001628280-22-010614.txt   1572567
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34655 | Film No.: 22855355
SIC: 2834 Pharmaceutical Preparations